Arrowhead Research ARWR Return on invested capital

Return on invested capital at other companies

Ionis PharmaceuticalsIONS

-80.3%+2,757pp

Assembly BiosciencesASMB

-396.2%+611pp

Arbutus Biopharma CorporationABUS

111.6%+71.5pp

Ultragenyx PharmaceuticalRARE

-475.4%+443pp

Beam TherapeuticsBEAM

-39.4%-8.8pp

Dyne Therapeutics, Inc.DYN

-188.2%+14.8pp

FAQ

What is Arrowhead Research's return on invested capital?

Arrowhead Research (ARWR) reported return on invested capital of -38.8% in Q1 2026.

How has Arrowhead Research's return on invested capital changed year-over-year?

Arrowhead Research's return on invested capital decreased by 77.6% year-over-year, from -21.8% to -38.8%.

What is the long-term trend for Arrowhead Research's return on invested capital?

Over 4 years (2021 to 2025), Arrowhead Research's return on invested capital has grown at a -19.9% compound annual growth rate (CAGR), from -50.6% to 20.9%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.